FDA Investigator Hector A Carrero
Hector A Carrero has conducted inspections on 15 sites in 5 countries as of 24 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
15
Last Inspection Date:
24 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Spain,
Germany,
Hungary,
Denmark
FDA Investigators that have inspected at least one site in common with Hector A Carrero:
Adam R Cooke,
Alan L Truong,
Amy H Ruble,
Anastasia M Shields,
Andrew A Hoopes,
Andrey Sarafanov, PhD,
Anissa M Cheung,
Anita R Michael,
Anthony R Bucks,
Arulvathani P Arudchandran,
Ashley A Mutawakkil,
Barbara M Frazier,
Barbara T Carmichael,
Bei Y He,
Bharat Khurana,
Billy M Battles,
Bo Chi, PhD,
Bonita S Chester,
Brett R Havranek,
Brittany D Terhar,
Burnell M Henry,
Carl A Huffman, III,
Carlos M Gonzalez,
CDR Thomas R Berry, PPh,
Charles L Zhou,
Cherrie A Zachary,
Christian D Lynch (CDL),
Christine A Harman, PhD,
Claire M Minden,
Cody D Rickman,
Constantin Y Philopoulos,
Craig D Zagata,
Cynthia Jim, CSO,
Damaris Y Hernandez,
Darcel T Bigelow,
David J Eide,
Devaughn Edwards,
Donald C Obenhuber, PhD,
Donald L Myers,
Dr. Carmelo Rosa,
Dusty F Snoeberg,
Ellen Huang,
Eric M Mueller, PharmD,
Eric M Padgett,
Eric Peng,
Erika V Butler,
Erin C Hill,
Erin Hill (EH),
Gabriel R Mclemore,
Gayle S Lawson,
Gideon N Esuzor,
Grace I Cortesini,
Gwyn G Dickinson,
Helen Y Saccone,
Holly Brevig,
Ivan E Reyes,
Jacob G Lutz,
Jacqueline Mdiaz Albertini,
James E Keller, PhD,
James I Giefer,
Janet B Abt,
Jared P Stevens,
Jason F Chancey,
Jawaid Hamid,
Jazmine N Still,
Jeffrey D Meng,
Jennifer D Hollstrom,
Joseph A Piechocki,
Joseph F Owens,
Joseph George,
Joseph R Lambert,
Julianne C Mccullough,
Julie D Bringger,
Justin A Boyd,
Karen E D'orazio,
Kathleen D Culver,
Kathleen R Jones, PhD,
Kelly K Nachtigal,
Ken L Bowers,
Kevin D Kallander,
Kim Lthomas Cruse,
Ko U Min,
Kurt A Brorson, PhD,
Larry K Hampton,
Laura M Ricles,
Laurel A Beer,
Lawrence Carter, III,
Lewis K Antwi,
Lisa R Hilliar,
Marea K Harmon,
Margaret A Smithers,
Margaret M Annes,
Margaret Norton,
Marie F Morin,
Mary E Farbman, PhD,
Matthew M Schuckmann,
Matthew R Sleeter,
Meihong Liu,
Melanie M Walker,
Michael C Kennedy, PhD,
Michele L Forster, PhD,
Michele L Obert,
Michele M Falchek,
Michele Perry Williams,
Michelle Yclark Stuart,
Mihaly S Ligmond,
Monica Cburgos Garcia,
Monica M Mcclure,
Mra Davism,
Nancy G Schmidt,
Nutan Mytle,
Obinna R Echeozo,
Omotunde O Osunsanmi,
Ou Ma,
Pankaj H Amin,
Paul A Bonneau,
Paula A Trost,
Penny H Mccarver,
Perry H Gambrell,
Prabhu P Raju,
Priscilla M Pastrana,
Ralph H Vocque,
Randy L Clarida,
Rebecca E Dombrowski,
Rhonda Alexander,
Richard L Rutherford,
Rita K Kabaso,
Robert C Coleman,
Robert J Ham,
Robert Jennings,
Roger F Zabinski,
Rose Ashley,
Russell J Glapion,
Sarah E Rhoades,
Saundrea A Munroe,
Scott A Golladay,
Sean R Marcsisin,
Seneca D Toms,
Shafiq S Ahadi,
Sheri L Stephenson,
Shirley J Berryman,
Sidney B Priesmeyer,
Simone E Pitts,
Stephanie Mangigian, MS/OSH, RN,
Steven D Kehoe,
Steven P Donald,
Steven R Bauer,
Susan M Jackson,
Susan M Turcovski,
Susan T Hadman,
Susanna E Ford,
Tamika D Cathey,
Tammara A Stephens,
Tara L Breckenridge,
Tara L Greene,
Teresita C Mercado,
Thomas R Withers,
Toyin B Oladimeji,
Unnee Ranjan,
Vicky C Stoakes,
Victoria A Wagoner,
Viviana Matta,
Viviana R Ramirez,
Vlada Matusovsky,
Walsworth,
Yun Wu, PhD,
Zhong Li, PhD,
Zi Qiang Gu
Hector A Carrero's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2022 | EIR | Patheon Manufacturing Services LLC - EIR, 2022-04-15 |
March, 2019 | EIR | IDT Biologika GmbH - EIR, 2019-09-18 |
March, 2019 | FDA 483 | IDT Biologika GmbH - Form 483, 2019-03-08 |
March, 2019 | FDA 483 Response | IDT Biologika GmbH - Form 483R, 2019-03-25 |
April, 2018 | FDA 483 | Siwa Biotech Corp. - Form 483, 2018-04-27 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more